A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Hepatology · 2,642 citations
https://doi.org/10.1097/hep.0000000000000520
S
Samer Gawrieh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
196
Papers
10.6K
Citations
37
h-index
82
i10-index
Samer Gawrieh is an academic researcher from Indiana University School of Medicine. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Liver Diseases and Immunity. The author has an h-index of 37, co-authored 167 publications.
ORCID: 0000-0002-2056-4909Papers by this author
worksA multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Journal of Hepatology · 2,472 citations
https://doi.org/10.1016/j.jhep.2023.06.003
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Annals of Hepatology · 734 citations
https://doi.org/10.1016/j.aohep.2023.101133
High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population
2021 · Hepatology · 274 citations
https://doi.org/10.1002/hep.32207
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
2021 · Journal of Hepatology · 267 citations
https://doi.org/10.1016/j.jhep.2021.02.034
Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
2019 · Clinical Gastroenterology and Hepatology · 258 citations
https://doi.org/10.1016/j.cgh.2018.12.031
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat